ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore

The Bulls N’ Bears ASX Runner of the Week is…biopharma minnow Zelira Therapeutics, which landed a US$33 million funding deal to fast-track its autism drug towards FDA approval.